226 related articles for article (PubMed ID: 22037854)
1. Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.
Teles C; Smith A; Lang S
Antimicrob Agents Chemother; 2012 Jan; 56(1):458-63. PubMed ID: 22037854
[TBL] [Abstract][Full Text] [Related]
2. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis.
Hsu RB; Lin FY
Cardiology; 2006; 105(4):234-9. PubMed ID: 16534200
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis
Kebriaei R; Rice SA; Stamper KC; Seepersaud R; Garcia-de-la-Maria C; Mishra NN; Miro JM; Arias CA; Tran TT; Sullam PM; Bayer AS; Rybak MJ
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962347
[TBL] [Abstract][Full Text] [Related]
4. Mitis group streptococci express variable pilus islet 2 pili.
Zähner D; Gandhi AR; Yi H; Stephens DS
PLoS One; 2011; 6(9):e25124. PubMed ID: 21966432
[TBL] [Abstract][Full Text] [Related]
5. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
García-de-la-Mària C; Pericas JM; Del Río A; Castañeda X; Vila-Farrés X; Armero Y; Espinal PA; Cervera C; Soy D; Falces C; Ninot S; Almela M; Mestres CA; Gatell JM; Vila J; Moreno A; Marco F; Miró JM;
Antimicrob Agents Chemother; 2013 May; 57(5):2319-25. PubMed ID: 23478959
[TBL] [Abstract][Full Text] [Related]
6. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W
Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
[TBL] [Abstract][Full Text] [Related]
7. A case of Streptococcus mitis endocarditis successfully treated by linezolid.
Ng KH; Lee S; Yip SF; Que TL
Hong Kong Med J; 2005 Oct; 11(5):411-3. PubMed ID: 16219964
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
9. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
Garcia-de-la-Maria C; Xiong YQ; Pericas JM; Armero Y; Moreno A; Mishra NN; Rybak MJ; Tran TT; Arias CA; Sullam PM; Bayer AS; Miro JM
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264848
[TBL] [Abstract][Full Text] [Related]
10. Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis.
Kikuchi K; Enari T; Minami S; Haruki K; Shibata Y; Hasegawa H; Katahira J; Totsuka K; Shimizu K
J Antimicrob Chemother; 1994 Nov; 34(5):687-96. PubMed ID: 7706164
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria.
Adams HM; Joyce LR; Guan Z; Akins RL; Palmer KL
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223392
[TBL] [Abstract][Full Text] [Related]
12. Contribution of plasminogen activation towards the pathogenic potential of oral streptococci.
Itzek A; Gillen CM; Fulde M; Friedrichs C; Rodloff AC; Chhatwal GS; Nitsche-Schmitz DP
PLoS One; 2010 Nov; 5(11):e13826. PubMed ID: 21072208
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023.
Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD
Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250
[TBL] [Abstract][Full Text] [Related]
14. Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
Zapata B; Alvarez DN; Farah S; Garcia-de-la-Maria C; Miro JM; Sakoulas G; Bayer AS; Mishra NN
Curr Microbiol; 2018 Aug; 75(8):1062-1067. PubMed ID: 29651552
[TBL] [Abstract][Full Text] [Related]
15. A patient with penicillin-resistant viridans group streptococcal endocarditis and unusual reactions to vancomycin.
Apiwattanakul N; Wanitkun S; Chongtrakool P; Sirinavin S
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1088-91. PubMed ID: 19062700
[TBL] [Abstract][Full Text] [Related]
16. The role of streptococcal plasmin(ogen) binding in infective endocarditis.
Teles C; Smith A; Ramage G; Lang S
Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):127-9. PubMed ID: 20835741
[TBL] [Abstract][Full Text] [Related]
17. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
Piper KE; Rouse MS; Ronningen KL; Steckelberg JM; Wilson WR; Patel R
Antimicrob Agents Chemother; 2000 Sep; 44(9):2554-6. PubMed ID: 10952616
[TBL] [Abstract][Full Text] [Related]
18. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.
Levy CS; Kogulan P; Gill VJ; Croxton MB; Kane JG; Lucey DR
Clin Infect Dis; 2001 Aug; 33(4):577-9. PubMed ID: 11462199
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus mitis/oralis Causing Blood Stream Infections in Pediatric Patients.
Basaranoglu ST; Ozsurekci Y; Aykac K; Aycan AE; Bıcakcigil A; Altun B; Sancak B; Cengiz AB; Kara A; Ceyhan M
Jpn J Infect Dis; 2019 Jan; 72(1):1-6. PubMed ID: 30175731
[TBL] [Abstract][Full Text] [Related]
20. Clinical isolates of
Sarangi J; Ido A; Ito M; Iinuma C; Doyama Y; Jin W; Wachino J-i; Suzuki M; Iguchi M; Yagi T; Arakawa Y; Kimura K
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0117923. PubMed ID: 38415648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
